Brief: Armata Pharmaceuticals Commissions cGMP Manufacturing Facility In Los Angeles
10/11/2025 12:04
Nov 10 (Reuters) - Armata Pharmaceuticals Inc ARMP.A: ARMATA PHARMACEUTICALS INC - COMMISSIONS CGMP MANUFACTURING FACILITY IN LOS ANGELES ARMATA PHARMACEUTICALS INC - FDA NOTIFIED OF PRODUCTION COMMENCEMENT; NO ISSUES REPORTED Source text: ID:nPn56dVy5a Further company coverage: ARMP.A ((reuters.briefs@thomsonreuters.com;))
Recent news on Armata Pharmaceuticals
See all newsBrief: Armata Pharmaceuticals Announces First Quarter 2026 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Delays Announcement Of Fourth Quarter And Full-Year 2025 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product Designation
Armata Pharma jumps on US FDA nod for late-stage infection trial
Brief: Armata Pharmaceuticals Commissions cGMP Manufacturing Facility In Los Angeles